Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study

Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study

Background: Health technology assessment (HTA) has increased in importance in supporting payer decision making by assessing the relative effectiveness and cost effectiveness of new medicines. Thus, pharmaceutical companies need to address the HTA requirements early during development to improve reim...

Full description

Bibliographic Details
Main Authors: Ting Wang, Neil McAuslane, Lawrence Liberti, Helga Gardarsdottir, Wim Goettsch, Hubert Leufkens
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Pharmacology
Subjects:
metrics
reimbursement
health technology assessment
market access
drug development
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.594549/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.594549/full

Similar Items